Isolation of circulating tumor cells from glioblastoma patients by direct immunomagnetic targeting
David T. Lynch(Mayo Clinic in Arizona), Therese M. Becker(Liverpool Hospital), Branka Powter(Ingham Institute), Paul de Souza(St. George Hospital), Eng‐Siew Koh(Liverpool Hospital), Joseph W. Po(Camden and Campbelltown Hospitals), Matthias Jaeger(UNSW Sydney), Mark Sheridan(Liverpool Hospital), Tara L. Roberts(Camden and Campbelltown Hospitals), Renata Bazina(Liverpool Hospital), James van Gelder(Liverpool Hospital), Balsam Darwish(Liverpool Hospital), Adam Cooper(Liverpool Hospital), Simon McKechnie(Liverpool Hospital), Celine Garrett(Ingham Institute)
Cited by 0
Related Papers
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
|New England Journal of Medicine|2012|2.8k
Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study
|The Lancet Oncology|2015|1.4k
HIN-200 Proteins Regulate Caspase Activation in Response to Foreign Cytoplasmic DNA
|Science|2009|822
AIM2 and NLRP3 inflammasomes activate both apoptotic and pyroptotic death pathways via ASC
|Cell Death and Differentiation|2013|507